posted on 2013-02-20, 22:10authored byNaveen K. Vaidya, Libin Rong, Vincent C. Marconi, Daniel R. Kuritzkes, Steven G. Deeks, Alan S. Perelson
Plasma HIV-1 RNA level (a–d), and V38A mutant virus proportion (e–h), for different V38A mutant virus fitness costs (a,e), initial V38A mutant virus proportion (b,f), initial T cell counts (c,g) and T cell source rate (d,h). Parameters used are the average values of P1, P2, P3 in Table 1.